Evidence map›Paper›PMID 25941060›Full record

ReviewNature reviews. Nephrology2015

Long-term medical risks to the living kidney donor.

Ngan N Lam, Krista L Lentine, Andrew S Levey, Bertram L Kasiske, Amit X Garg

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 4 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 4 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Removing Disincentives to Kidney Donation: A Quantitative Analysis.Journal of the American Society of Nephrology : JASN · 2019
    Article
  13. Review
  14. Article
  15. Mood, body image, fear of kidney failure, life satisfaction, and decisional stability following living kidney donation: Findings from the KDOC study.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2018
    Article
  16. Follow-up Care of Living Kidney Donors in Alberta, Canada.Canadian journal of kidney health and disease · 2018
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ngan N LamDepartment of Medicine, Division of Nephrology, Western University, London Health Sciences Centre, 800 Commissioners Road East, London, ON N6A 4G5, Canada.
Krista L LentineDepartment of Internal Medicine, Division of Nephrology, Saint Louis University, 3635 Vista at Grand Boulevard, St. Louis, MO 63110, USA.
Andrew S LeveyDivision of Nephrology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.
Bertram L KasiskeDepartment of Medicine, Hennepin County Medical Center, 701 Park Avenue, Minneapolis, MN 55414, USA.
Amit X GargDepartment of Medicine, Division of Nephrology, Western University, London Health Sciences Centre, 800 Commissioners Road East, London, ON N6A 4G5, Canada.
Western University · CATufts Medical Center · US

Funding

Live Unrelated Kidney Donor & Sibling Follow-up StudyU01DK066013 · NIDDK · UNIVERSITY OF MINNESOTA · PI KASISKE, BERTRAM L · 2006 to 2016
$5.9M
Long-Term Health Outcomes After Live Kidney Donation in African AmericansR01DK096008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SEGEV, DORRY L. · 2013 to 2017
$3.8M
NIDDK NIH HHS R01‑DK096008NIDDK NIH HHS U01-DK066013-09
6 · The paper itself

Abstract

Living kidney donation benefits recipients and society but carries short-term and long-term risks for the donor. This Review summarizes the studies that underlie our current understanding of these risks in the first decade after donation, with a view to improving the informed consent process. Two studies report a higher risk of end-stage renal disease (ESRD) among donors than among healthy nondonors; however, the absolute 15-year incidence of ESRD is <1%. All-cause mortality and the risk of cardiovascular events are similar among donors and healthy nondonors, although one study provides evidence for a 5% increase in all-cause mortality after 25 years that is attributable to donation. Some evidence suggests that the 20-year incidence of gout is slightly higher among donors than among healthy nondonors. The risks of gestational hypertension or pre-eclampsia seem to be 6% higher in pregnancies among donors than in pregnancies among healthy nondonors. The incidences of acute kidney injury, kidney stones that require surgical intervention, gastrointestinal bleeding and fractures seem no higher among donors than among healthy nondonors, although some of these conclusions are based on a small number of events. Future studies must clarify the lifetime incidence of long-term outcomes, particularly in relation to a donor's age, race, and history of comorbidities.

Indexed as

Living DonorsAcute Kidney InjuryHumansKidney Failure, ChronicKidney TransplantationNephrectomyRisk AssessmentRisk FactorsTime Factors

Identifiers

PMID25941060
OpenAlexW1549243126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.